8-K: Universal Health Realty Reports Q4, Full-Year 2025 Earnings

Universal Health Realty Income Trust reported a decrease in net income and FFO per diluted share for the full year 2025, with Q4 net income also declining.

Summary

• Net income for the three-month period ended December 31, 2025, was $4.3 million, or $0.31 per diluted share, a decrease from $4.7 million, or $0.34 per diluted share, in Q4 2024.
• Funds from operations (FFO) for Q4 2025 decreased slightly to $11.74 million, or $0.85 per diluted share, compared to $11.76 million, or $0.85 per diluted share, in Q4 2024.
• Full-year 2025 net income was $17.6 million, or $1.27 per diluted share, down from $19.2 million, or $1.39 per diluted share, in 2024.
• Full-year 2025 FFO decreased to $47.7 million, or $3.44 per diluted share, from $47.9 million, or $3.46 per diluted share, in 2024.
• The decrease in Q4 2025 net income was primarily due to a $610,000 decrease in net aggregate income from various properties, partially offset by a $273,000 decrease in interest expense.
• A medical office building (MOB) in Amarillo, Texas, was vacated in Q4 2025 upon lease expirations, contributing to decreased income.
• The full-year 2025 net income decrease included a $1.0 million aggregate net decrease in income from properties (including $900,000 nonrecurring depreciation in Q3 2025) and a $610,000 impact from a 2024 property tax reduction not repeated in 2025.
• A fourth-quarter dividend of $0.745 per share, totaling $10.3 million, was declared on December 22, 2025, and paid on December 31, 2025.
• As of December 31, 2025, the company had $68.8 million of available borrowing capacity under its $425 million credit agreement, with $356.2 million outstanding.
• Construction commenced in February 2026 for Palm Beach Gardens Medical Plaza I, an 80,000 square foot MOB, with an estimated cost of $34 million, expected to be completed in Q4 2026.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a moderately negative report due to declining net income and FFO per share for the full year, coupled with significant industry-wide risk factors, despite a new development project.

Positives

• Interest expense decreased by $273,000, or $0.02 per diluted share, in Q4 2025 due to a lower average effective borrowing rate.
• The company maintains $68.8 million in available borrowing capacity under its credit agreement, providing financial flexibility.
• Initiation of the Palm Beach Gardens Medical Plaza I development represents a strategic investment in a new 80,000 square foot medical office building, with a 10-year master flex lease for approximately 75% of the space already secured by a UHS subsidiary.

Negatives

• Net income decreased by $337,000, or $0.03 per diluted share, in Q4 2025 compared to Q4 2024.
• Full-year 2025 net income decreased by $1.6 million, or $0.12 per diluted share, compared to full-year 2024.
• Funds from operations (FFO) decreased slightly for Q4 2025 and by $184,000, or $0.02 per diluted share, for the full year 2025.
• A medical office building in Amarillo, Texas, was vacated in Q4 2025 due to lease expirations, leading to decreased income.
• Full-year 2025 results were negatively impacted by a $610,000 property tax reduction recorded in 2024 that did not recur.

Risks

• Potential significant reductions in federal funding for state Medicaid programs, which could lead to reduced Medicaid payments to facility operators.
• Decreases in staffing availability and related increases in wage expenses for tenants due to shortages of nurses, clinical staff, and support personnel.
• Impact of government and administrative regulation on the healthcare industry.
• Declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions, including increases in uninsured/underinsured patients due to the expiration of enhanced ACA subsidies on December 31, 2025, business closings, and layoffs.
• Potential cost increases and disruptions related to supplies and building materials due to changes in foreign trade laws, increased trade restrictions, tariffs, or taxes on imports.
• Potential increases to other operating expenditures.
• Increased interest rates have substantially raised borrowing costs and reduced access to capital markets on favorable terms.
• Additional increases in interest rates could significantly and unfavorably impact future results of operations and capital markets access.

Future Outlook

Management expects future results to be influenced by various factors, including potential reductions in federal Medicaid funding, staffing shortages and increased wage expenses for tenants, government healthcare regulations, declining patient volumes due to macroeconomic conditions and the expiration of ACA subsidies, supply chain disruptions, and further increases in interest rates. The company is developing a new medical office building in Palm Beach Gardens, Florida, expected to be completed in Q4 2026, with a significant portion already pre-leased.

Management Comments

• The decrease in net income during the three-month period ended December 31, 2025, as compared to the fourth quarter of 2024, included a decrease of $610,000, or $0.04 per diluted share, primarily from a decrease in net aggregate income generated at various properties, partially offset by an increase of $273,000, or $0.02 per diluted share, from a decrease in interest expense.
• The decrease in net aggregate income during the fourth quarter of 2025 was primarily due to decreased income generated at a medical office building in Amarillo, Texas, which was vacated upon lease expirations.

Industry Context

StockSavvy.ai notes that the healthcare real estate sector, while generally stable, faces headwinds from rising interest rates impacting borrowing costs and capital market access, as well as broader healthcare industry challenges such as potential Medicaid funding cuts and staffing shortages affecting tenant profitability. The strategic development of new medical office buildings, particularly those co-located with acute care hospitals, aligns with a trend towards integrated healthcare campuses, which can offer long-term stability and tenant demand.

Comparison to Industry Standards

• NA

Related Party Transactions

• Entered into a ground lease with a wholly-owned subsidiary of Universal Health Services (UHS) for the development of Palm Beach Gardens Medical Plaza I.
• Engaged a wholly-owned subsidiary of UHS to act as project manager for the construction of Palm Beach Gardens Medical Plaza I.
• A wholly-owned subsidiary of UHS has executed a 10-year master flex lease agreement for approximately 75% of the rentable square feet of Palm Beach Gardens Medical Plaza I.
• Advisory fees paid to UHS were $1.426 million for Q4 2025 and $5.595 million for FY 2025.
• Lease revenue from UHS facilities was $8.297 million for Q4 2025 and $33.372 million for FY 2025.
• Other revenue from UHS facilities was $234 thousand for Q4 2025 and $933 thousand for FY 2025.
• Interest income on financing leases from UHS facilities was $1.345 million for Q4 2025 and $5.395 million for FY 2025.

Stakeholder Impact

• Shareholders may experience reduced dividend growth or stability if financial performance continues to decline, although the Q4 dividend was maintained.
• Tenants face potential challenges from staffing shortages, increased wage expenses, and changes in government healthcare funding, which could impact their ability to meet lease obligations.
• Creditors may view the company's slightly declining financial metrics with caution, though available borrowing capacity provides some comfort.
• Employees of the company and its tenants could be affected by industry-wide staffing issues and macroeconomic conditions.

Next Steps

• Continue marketing the vacated medical office building in Amarillo, Texas, to potential new tenants.
• Proceed with the development and construction of Palm Beach Gardens Medical Plaza I, with expected completion in Q4 2026.
• Monitor the opening of the Alan B. Miller Medical Center in Q2 2026, which is adjacent to the new Palm Beach Gardens MOB.

Key Dates

Recommendation

The company reported a decline in net income and FFO per diluted share for the full year 2025, indicating a challenging operating environment. While the new development project in Palm Beach Gardens offers future growth potential and a significant portion is pre-leased, current financial performance is weaker. The comprehensive list of industry-wide risks, including rising interest rates and potential healthcare funding cuts, suggests caution. Given the mixed results and identified risks, a 'hold' recommendation is appropriate for investors to monitor the execution of new projects and the impact of macroeconomic and industry headwinds.

Keywords

REIT, Healthcare Real Estate, Medical Office Building, Earnings Report, FFO, Net Income, Dividends, Real Estate Investment Trust, UHT, Universal Health Realty Income Trust